Background: Quality of life is recognized as an important additional outcome measure in clinical trials and health economic evaluations. The EQ-5D is an important generic health outcome instrument often used for economic evaluations as a complement with disease-specific outcome measures. In this study quality of life data was assessed using the EQ-5D-Y (new EQ-5D version for children and adolescents) and the Cystic Fibrosis Questionnaire (CFQ). The objective of the study is to evaluate the cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany.
Costs of outpatient medication for CF patients significantly depend on age, co-morbidities and other clinical parameters. Hence, non-optimal treatment could lead to a significantly higher burden for the healthcare system.
In March 2010 a National Action League for People with Rare Diseases (NAMSE) was founded. The NAMSE created a national plan of action for people with rare diseases for improving medical care in the field of rare diseases which was approved by the Federal Government in August 2013. Thus, two important areas of the research report have already been implemented. In a comparison of the areas of activity of the research report with those of the National Action Plan it becomes clear that priorities will be in the context of health services research in rare diseases, for example the introduction of centres of reference for rare diseases, measures to accelerate the diagnostic process and the promotion of research and information management in the future.
Citizen science projects in health-related research usually follow a crowdsourcing approach where laypersons primarily have a supplying role in data collection. By contrast, this article presents an approach on a much higher engagement level (co-creation) where a team of professional and citizen scientists jointly plans, implements, and evaluates a scientific study on a chronic disease from which the citizen (patient) scientists themselves suffer. We call this approach patient science; it systematically makes use of the patients’ expertise of living with the disease. This article describes the pilot project and conceptual differences compared to other participatory approaches in medical and health research. It elaborates on the implications of involving chronically ill people as co-researchers and, finally, reflects on the benefits and challenges of patient science.
International audienceObjective Objective of this study is to assess and evaluate resource use in outpatient treatment in Germany and to compare it with remuneration. Methods Outpatient treatment was evaluated in seven different centers for pediatric and adult CF patients. Data was recorded during one representative month in 2006. A micro-costing approach was used to value resource use data. Results For outpatient treatment mean costs (excluding drugs) of 488 € per patient per quarter occurred. Correlation analysis identified significant cost drivers including age and co-morbidities (pancreatic insufficiency, hepatobiliary complications, lung function capacity or bacterial lung colonization). Remuneration covered only 51% of the total costs (252 € per patient/quarter). Conclusions As the human resources available to these centres today are already below the requirements set by the European consensus for standards of CF care it will be important for of a high level of patient care to reach a cost-covering remuneration scheme
BackgroundTo compare improvement in quality of life (QoL) and symptoms' relief in vertebral compression fractures (VCF) due to osteoporosis for patients undergoing balloon kyphoplasty (BKP) to those undergoing non-surgical management (NSM) in a real-life setting.MethodsIn this prospective, comparative study, quality-of-life was evaluated in eight centres in Germany between 2005 and 2008, for 82 patients, with the EQ-5D questionnaire, and the Roland Morris Disability Questionnaire (RMDQ).ResultsBKP patients demonstrated a statistical and clinical significant higher improvement in EQ-5D than NSM patients, 0.44 and 0.25 from baseline to 12 months, respectively. Moreover, BKP patients showed a clinically relevant improvement in the RMDQ by 6.25 from baseline to 12 months, whereas NSM patients had no significant improvement in the RMDQ.ConclusionsThis study demonstrates for VCF patients that in real-life quality of life for BKP patients improves more than for NSM patients; confirming the results of a large randomized clinical trial.
Zusammenfassung
Hintergrund
Um eine spezialisierte Versorgung von Menschen mit seltenen Erkrankungen (sE) zu gewährleisten, wurden zahlreiche Zentren für Seltene Erkrankungen (ZSE) gegründet. Für die ambulante Behandlung von Betroffenen in Krankenhäusern steht dabei eine Vielzahl von Versorgungs- und Vergütungsformen zur Verfügung. Studien zu einzelnen sE ergaben bereits Hinweise auf Defizite in Bezug auf eine kostendeckende Vergütung der ZSE.
Ziel der Arbeit
Untersuchung der aktuellen Versorgungs- und Vergütungsstrukturen in den ZSE und die Entwicklung von Ansätzen für zukünftige nachhaltige Vergütungsstrukturen.
Material und Methoden
Mittels Fragebogenerhebung wurden zunächst ZSE in Deutschland zu ihrer Versorgungs- und Vergütungsform befragt. Im Rahmen zweier Fokusgruppen- und eines Experteninterviews mit Vertreter:innen der ZSE, der Kostenträger, der Gesundheitspolitik sowie Patient:innen wurden im Anschluss die aktuellen Versorgungs- und Vergütungsformen, Möglichkeiten der zukünftigen Gestaltung der Versorgung von Menschen mit sE sowie Ansätze für eine leistungsorientierte Vergütung diskutiert. Das Material wurde inhaltsanalytisch nach Kuckartz ausgewertet.
Ergebnisse und Diskussion
39 Zentren beteiligten sich an der Fragebogenerhebung. 38 % dieser Zentren werden über eine Pauschale für Hochschulambulanzen (HSA) vergütet, deren Höhe stark variiert. 41 % weisen eine Mischvergütung aus HSA-Pauschale und weiteren Vergütungsformen auf. In den Interviews wurde eine Unterdeckung der Kosten in den ZSE mit Auswirkungen auf die Patientenversorgung benannt und zur Sicherstellung einer nachhaltigen Versorgung Handlungsbedarf zur Weiterentwicklung der Vergütungsstrukturen festgestellt. Eine „Sonderpauschale für sE“, die den besonderen zeitlichen Bedarf in der Versorgung von Menschen mit sE abbildet, wurde als möglicher nachhaltiger Vergütungsansatz präferiert.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.